![]() | ![]() | | |
| Home | Topics | About | News | Publications | Consultations | Search | Links | Contacts | Help |
| Consultations > Health & Nutrition |
< Previous | Contents | Next > EFFECTIVE AND COST-EFFECTIVE MEASURES TO REDUCE ALCOHOL MISUSE IN SCOTLAND: A LITERATURE REVIEWCHAPTER EIGHT BRIEF INTERVENTIONS
Introduction8.1 A brief intervention is a time-limited intervention focusing on changing patient behaviour with respect to alcohol consumption through motivational counselling. There is a more extensive literature in this area than for many other interventions. The studies reviewed are summarised briefly in tables 8.7 (effectiveness) and 8.8 (cost-effectiveness) at the end of the chapter. Effectiveness of brief interventionsTypes of brief interventions. 8.2 A brief intervention has been defined as having 5 essential steps (Fleming and Manwell 1999);
8.3 The counselling strategy used in brief interventions has also been summarised as FRAMES (Miller and Rollnick, 1991 cited in OConnor and Schottenfeld, 1998);
8.4 The precise content of the brief interventions evaluated in trials is variable, however. In this section, reviews have been included if they refer to brief interventions, minimal interventions or extended brief interventions. Brief interventions are mainly used to reduce alcohol consumption in people drinking above recommended levels but who are not dependent. Brief interventions may also have a role in improving compliance with other treatment regimens for alcohol dependent patients (Fleming and Manwell, 1999). Effectiveness of brief interventions. 8.5 Most studies have found that brief interventions are effective in reducing alcohol consumption for at least 12 months in patients who are not alcohol dependent, and when compared with no intervention or usual care. A number of outcome measures are used including levels of alcohol consumption, change from heavy to moderate drinking and biochemical markers of alcohol consumption. 8.6 Formal meta-analysis of RCTs is difficult because of the variability in the content of the interventions, the population groups studied and the outcome measures used but this has been attempted in 3 reviews (Freemantle et al 1993; Poikolaninen, 1999; Wilk, Jensen and Havighurst, 1997). The former pooled results from 6 trials and estimated the effect of brief intervention as a 24% reduction in alcohol consumption (95% CI; 18%-31%). The second study analysed changes in alcohol consumption and concluded that there was no significant effect for brief interventions in either men or women. Extended brief interventions were effective for women; in men the effect size was similar but not significant. The last study analysed the proportion of patients reducing or moderating their drinking and concluded that those receiving motivational interventions were twice as likely as controls to change their behaviour (Odds Ratio 1.95; 95% CI; 1.66-2.30). 8.7 Five of the 7 studies included by Poikolaninen and all of the studies included by Freemantle et al were also included in the 8 studies pooled by Wilk et al. These meta-analyses were conducted to very high standards but have used different measures of effectiveness to arrive at different conclusions. Table 8.1 Pooled results from 8 RCTs of brief interventions.
8.8 Some studies that have found minimal differences between intervention and control groups achieved reductions in alcohol consumption in both groups (Fleming and Manwell, 1999). This may be due to the research process drawing attention to drinking behaviour in the control group. One study that found increases in alcohol intake, though not statistically significant, is cited (Richmond et al, 1995 cited in Poikolainen, 1999). The same study showed a non-significant difference in the percentage moderating their alcohol use (Wilk, Jensen and Havighurst, 1997). Population groups. 8.9 Brief interventions have been evaluated across a wide range of population groups, in terms of demographic characteristics; men, women, and the elderly. However, the most difficult cases, in terms of their drinking behaviour are often excluded or may self-select out of studies at the recruitment or assessment stage. Brief interventions have not been shown to be effective in pregnant women but this may be because of the high abstinence rates amongst the women at the time of the intervention (Chang et al, 1999 cited in NIAAA, 2000). Settings. 8.10 The majority of studies have been conducted in primary care settings. Brief interventions have also been shown to be effective in inpatient settings, although the two studies cited are rated as being of relatively low quality and conducted more than 10 years ago (Annti-Poika et al, 1988; Chick et al, 1985 cited in Wilk et al 1997). One small study has also shown an effect in a hypertension clinic (Maheswaran et al, 1992 cited in Wilk et al 1997). Interventions in emergency room (A&E) settings have been effective in reducing alcohol consumption or securing referral into treatment (NIAAA, 2000). Providers. 8.11 Doctors have delivered the brief interventions in the majority of studies. Nurses and health educators have also been effective in delivering brief interventions. Intensity of intervention. 8.12 No significant difference in effectiveness was found between one session or more than one session (Wilk et al, 1997). Although the meta-analysis by Poikolainen, 1999, appears to support extended brief interventions, the effect size for brief interventions was similar but did not reach statistical significance. Quality and relevance of the evidence. 8.13 Although the quality of the reviews is variable, overall they provide substantial support for the effectiveness of brief interventions in reducing alcohol consumption. The reviews by Fleming and Manwell, Freemantle et al, Poikolainen and Wilk et al are the most comprehensive. The only study cited suggesting that brief interventions increase alcohol consumption was not statistically significant. Potential for publication bias, that is the non-reporting of negative results, may still exist. 8.14 What is less clear is the generalisability of the results. The practitioners delivering interventions in research settings will be highly motivated and the effects may not be completely replicated in routine practice. Some groups are clearly excluded from the scope of the intervention but the process of consent for research studies means that the participants in the trial are self-selecting. 8.15 At least six of the reported trials were conducted in the UK and the effectiveness results should be relevant to Scotland. The Cost-Effectiveness of Brief Interventions8.16 Brief interventions for alcohol treatment have been shown to be cost-effective in published research. One of the major contributing factors to this high level of cost-effectiveness is that these interventions are relatively cheap in terms of inputs. The inputs to cost-effectiveness investigations of brief interventions include three major stages. Patients must be screened for alcohol problems, assessed for suitability for treatment and then costs of the actual treatment quantified and valued. The major input for the former two categories is the time of GPs plus any associated overheads and packages used. The costs of treatment will be highly dependent upon the intervention in question. Resource inputs 8.17 Few studies exist which document the cost-effectiveness of alcohol treatments in sufficient detail as to be termed full economic evaluations. Fleming et al (2000) undertook a cost-benefit analysis of physician advice regarding problem drinking, in the USA. The authors evaluated a programme of brief advice in general practice for drinking over threshold limits versus no treatment. The no treatment group received a booklet on general health issues. The treatment group received the booklet and were scheduled to see their GP for the brief intervention, including a workbook of current health behaviour, a review of the prevalence of problem drinking, a list of the adverse effects of alcohol, a worksheet on drinking cues, a drinking agreement in the form of a prescription and drinking diary cards. The intervention was based on MRC protocols and consisted of two 15-minute appointments a month apart. 8.18 Patients received a follow up call from the clinic nurse two weeks after each GP meeting. The clinic resources and patient time and travel required to deliver the intervention are summarised below. Table 8.2 Resource inputs to a brief intervention - example
8.19 Practitioner time was estimated by using salary cost for the duration of the event and adding 25% for overheads. Patient time for the intervention included waiting and travel time. The total treatment cost of the clinic was estimated at $64 933 (£44 230). The cost per patient was $205 (£140) and total economic cost $80 210 (£54 640). 8.20 Wutzke et al (2001) investigated the question of whether brief interventions are cost-effective in reducing alcohol consumption. The direct costs of providing an alcohol treatment programme in primary care were examined, including costs of treatment included marketing the WHO's Drink-less package to GPs, training and support costs, and the cost of counselling at risk drinkers. 8.21 Three support strategies were used, a control group (no initial training or on-going support), a no support group (five minutes of initial training with no further contact or support), and a maximal support group (five minutes training plus alternate telephone and personal visits every two weeks). Marketing costs were taken from Gomel et al (1998) who evaluated three strategies for recruiting GPs to the WHO Drink-less package, and found the telemarketing option to be the most cost-effective. Cost of marketing was found to be AUS$2.16 per GP or AUS$5.35 per successful approach (not all agreed to use package). 8.22 Screening and counselling 'at risk' drinkers followed strict protocols and took 5 minutes of GP time, and the costs were taken from the Medicare Fee Schedule. Table 8.3 shows the estimated average costs of delivering the intervention (1996 Australian dollars). Total costs for implementing the intervention nationally would be AUS$4.3 million for the control strategy, AUS$7.5 million for the no support and AUS$12.8 million for the maximal support option. The cost per patient counselled in UK currency were £7.56 for the control group, £6.80 for the no support group and £7.60 for the maximal support group. Table 8.3 Intervention costs for Drink-less
8.23 In a study of alcohol treatment in Sweden, Lindholm (1998) used results from controlled trials showing short-term effectiveness combined with epidemiological studies of alcohol and mortality links. In the model, if people reduce their drinking, life expectancy is expected to increase. The differences in mortality between moderate and heavy drinkers are calculated in terms of life years gained by switching drinkers from the 'high' to 'moderate' drinking level. Different relative risks and proportions changing from 'high' to 'moderate' are presented to assess the impact on cost-effectiveness, based on cohorts of 'high' and 'moderate' drinkers. The intervention is a hypothetical programme of primary care advice to reduce individual's drinking from a 'high' to a 'moderate' level. GP and nurse advice are modelled. 8.24 The costs per patient of the intervention are CAGE screening of 120ECU, GP visit of 130 ECU, visit to district nurse of 40 ECU and GT tests costing 1 ECU. Yearly health care costs per individual for moderate and heavy drinkers are presented, ranging from 700ECU (£432) (moderate 40-44 year olds) to 2 800ECU (£1 730) (Heavy, 65-69 year olds). Costs are discounted at 5%. Effectiveness of brief interventions: Alcohol consumption and health outcomes 8.25 The population in Fleming's study were patients aged 18-65 years attending routine general practice appointments and reporting drinking above threshold limits (defined as men consuming >14 drinks and women consuming >11 drinks per week), and comprised 482 men and 292 women. Health outcomes were based on self-reported alcohol consumption, at six and twelve months, completing a timeline follow back. The average number of drinks in the past seven days declined by 39.5% at six months and 40.0% at 12 months. Binge drinking reduced by 49.1% (6 months) and 45.7% (12 months), which was significantly greater than the reduction in the control group. 8.26 Wutzke's estimates of post treatment consumption came from the WHO Phase 2 trial and outcomes were also presented as life years saved. Estimates from the WHO trial found that baseline alcohol consumption fell by 28% in the intervention group after treatment. Potential deaths from alcohol related illnesses were then applied to the data to estimate the number of life years saved following implementation of the programme. The estimated life years saved were 674, 1285 and 1972 in the control, no support and maximal support strategies. Wider consequences 8.27 Wutzke's work was based exclusively on costs and benefits to the health care provider and the individual patient. Fleming provided detailed treatment costs, and unit costs were provided for clinic costs for screening, assessment, primary visit, a follow up visit for patients in the intervention group and clinic and training costs, using 1993 dollars. Fleming also estimated the wider economic costs from a societal perspective, including patient and health care costs and consequences, and cost savings to the legal system following treatment. Patient costs included travel and lost work time. However, health benefits to patients were measured in terms of drinking outcomes but not included in the aggregated results. The exposition therefore resembles the cost-offset literature rather than a cost-effectiveness study. The estimated magnitudes of these wider economic costs are provided below. Cost-effectiveness 8.28 In the Drink-less study, the average cost per life year saved was estimated to be AUS$645, AUS$581 and AUS$653 for the control, no support and maximal support strategies respectively, compared to 'do nothing' baseline. Compared to the control, each year of life costs $1,223 (£435) comparing minimal support with control and AUS$1,873 (£666) comparing maximal intervention with control. The results are based on the assumption that effects last 10 years. A discount rate of 3% was applied to all costs and benefits occurring in the future. The Drink-less package appears to offer a cost-effective means of reducing alcohol consumption and saving life years. Costs are very low compared to many programmes currently in operation in Australia. 8.29 The wider economic costs and benefits in Fleming et al's analysis were not combined with health outcomes, hence are not strictly cost-effectiveness results. Savings in emergency room visits and hospital use were $195,448 (£133,134) compared to the control. However, whilst the cost of hospitalisations were significantly different from zero, the difference in the cost of emergency departments was not statistically significant. In terms of crime costs, a difference in the costs of legal events (substance abuse, theft, forgery, assault) was $18,963 but not statistically significant. A difference of $209,108 for motor vehicle events was also not significant. Total savings of $228,071 also failed to satisfy significance testing (p=.14). The method of calculation was unclear. 8.30 Summing the total economic costs and benefits, the average benefit per subject was $1151 and the benefit-cost ratio 5.6:1 (or $56,263 in total benefit for every $10,000 invested in such programmes). However, it should be noted that such programmes may be subject to diminishing returns in a particular area and such benefit cannot be bought by continually investing sums of $10,000 into treatment as the greatest gains are likely to be exhausted first. However, as with many US studies, this claims to be a cost-benefit study but is actually another cost-offset study, due to the omission of any valuation of patient health benefits which are implicitly valued as zero. Some of the crime categories have few cases, making costs hard to extrapolate. Cost data are, on the whole, well presented although methodologies are excluded in the case of criminal justice costs. Fleming found the total economic benefit of the brief intervention to be $423,519 (£288,490) (95% CI $35,947-$884,848), the results being significantly positive although the 95% confidence interval is particularly large. 8.31 In Lindholm's study, cost-effectiveness was estimated based on assumptions regarding the proportion of drinkers changing from 'heavy' to 'moderate'. Based on 20% changing and a relative risk of mortality of heavy to moderate drinkers of 2, the 25 visit intervention cost 200ECU (£123.50) per life year saved (LYS). With a relative risk of mortality of 1.25, with 2% changing from heavy to moderate drinking status, the cost was 144,000ECU (£88,900) / LYS. If nurses give advice, as opposed to GPs, savings are greater than costs if effectiveness exceeds 10%. With the lowest effectiveness and relative risk figures, cost was 108,000ECU (£66,700) / LYS for the 25-visit and 20,000ECU (£12,350) / LYS for the 5-visit intervention programme. 8.32 Lindholm concludes that brief interventions delivered by GPs are cost-effective if the lasting treatment effect is about 1%. A 25-visit intervention is considered to be cost-effective if effectiveness is 2% and relative risk of mortality is greater than 1.5. Lower wages amongst nurses causes the cost-effectiveness of a nurse led intervention to be greater. However, the effectiveness of a nurse-led intervention is unknown. Although the message is clear from Lindholm's results, the author points to potential bias in trials as participants are often different from non-participants. Furthermore, the results are sensitive to changing the parameters involved, as changes in the assumptions behind the model result in large changes in the cost-effectiveness ratios. Quality and relevance of evidence 8.33 The studies outlined above illustrate brief interventions to be relatively cost-effective, due to fairly high levels of effectiveness and low costs. Fleming's study is effectively a cost-offset study, as individual health benefits are subsumed. The results are unlikely to have much relevance to Scotland. UK data do not tend to show the large benefit:cost ratios found in the USA. It also must be remembered that the utilisation of health care in the USA shows very different patterns to the UK, and the health care system is based on an insurance system that operates differently to the UK. Cost differences for health care interventions are also likely between the two countries. 8.34 A crucial difference between the studies is the way in which health outcomes are dealt with. Outcomes are expressed in alcohol consumption in Fleming's work, whilst Wutzke and Lindholm use life years saved. The advantage of the latter is that comparison with other health care interventions is facilitated. Wutzke's study offers potential for modelling a similar strategy in Scotland. Local costs could be estimated to replicate the study and assess the potential cost-effectiveness for this package in Scotland. 8.35 Finally, it should be emphasised that generalising the results of economic evaluations should be undertaken with extreme caution. Evaluations carried out in insurance-based health care systems and overseas where the prevalence and characteristics of alcohol related problems are different to Scotland should not be considered as directly applicable to Scotland. Incentives to use treatment and other health care services, and the impact of treatment on other costs, such as crime, should not be taken and applied directly to the Scottish scenario. Modelling of results for Scotland8.36 The published literature on brief interventions can be used to estimate the cost-effectiveness of these interventions in the UK, by applying local costs to the main study findings. However, evidence is scarce as few papers include resource use and unit costs in their analysis. Fleming et al (2000) conducted a cost-benefit analysis of brief GP advice with regard to problem drinking. They included health care costs and wider social costs using data from Project TrEAT, a randomised controlled trial. Based on a control group (n=382) and a treatment group (n=392), alcohol use, accident and emergency (A and E), hospital days and legal events were recorded for the two populations. Costs 8.37 In this simulation, local (UK) costs are applied to the resource use data to estimate the cost-effectiveness ratios that may be expected if the treatment programme was replicated in the UK. Obviously these are only estimates and the results, especially treatment effectiveness, will be determined by particular characteristics of the population in the parent study. Table 8.5 shows the costs of the brief intervention programme, based on UK costs. GP costs (including overheads) of £1.92 per minute are used, whilst practice nurse time is estimated at £0.30 per minute (Netten and Curtis, 2000). It should be noted that all GP time is costed using a 'higher bound' estimate including overhead costs for GP practice. Table 8.5 Costs of the brief intervention programme, using UK costs 1999-2000
8.38 The intervention requires that patients are screened and assessed before being given a brief intervention. Fleming's study showed that 8,962 patients were screened and assessments were conducted for 1,481 patients to provide primary interventions for 392 patients. Therefore 22.8 screenings and 3.78 assessments are required for every patient receiving a primary care intervention. The total intervention costs for one individual receiving a brief intervention are derived as follows:
Training costs will vary according to assumptions about workload. The figure used here assumes 92 interventions per year. No other implementation costs have been included. Consequences Resource savings 8.39 In terms of health care utilisation, the table below shows the number of events per patient in the previous 12 months at follow up. An average patient in the intervention group experienced 0.07 fewer A and E visits and 0.53 fewer hospitalised days compared to the control group. Based on a cost of £44 per A and E attendance and £199 per hospital day (Information and Statistics Division 2000), the cost savings per patient are £3.08 (A and E) plus £105.47 (hospital days). Table 8.6 Health care utilisation by intervention and control patients
8.40 Fleming's estimates of legal consequences include too few events to provide a meaningful comparison. However, if we look at motor vehicle events, there are 78 events in the treatment group and 95 in the control at follow up. This converts to 0.20 per patient (Treatment) and 0.25 (control). The difference of 0.05 can be multiplied by the cost per vehicle crime of £890 (Home Office, 2000) to give a saving of £44.50 per individual. Health outcomes 8.41 Fleming et al found the average reduction in alcohol consumption was 45.7 % at the 12 month follow up. This is the same order of magnitude as the treatment groups in studies included in the effectiveness reviews. 8.42 Based on Wutzke et al (2001) examining brief interventions in New Zealand, using a basic 'no support' strategy, a total of 6,743 life years were estimated to be saved for a population of 204,587 counselled. This is 0.033 life years per patient. Costs and consequences 8.43 If we assume the cost per patient of delivering a brief intervention is £86.74 and that life years saved are 0.033 then the cost of saving one life year is £2,628. (A lower estimated cost of £1,446 per life year saved can be generated by modelling the intervention on the basis used in Wutzke.) In terms of cost offsets, based on Fleming's (2000) estimates, and using Scottish costs, the estimated health care savings from A and E attendances and hospitalised days avoided is £108.55. Therefore a cost saving of £21.81 per patient can be estimated. In addition, if vehicle crimes are included the saving increases sharply to £66.31. However, some care should be exercised in interpreting these results. The saving represents the value of resources that are released but it is unlikely that financial savings of the same magnitude could be realised. Limitations of the simulation. 8.44 The simulation provides some outline figures against which actual policies could be monitored. The figures for costs include an allowance for additional GP or nurse time for screening and delivering the intervention. In practice, it is unclear how this additional resource would be allocated but it is not assumed that these interventions are undertaken by substituting other primary care activity. The costs include some training element but do not include any direct implementation costs. A direct programme of implementation may be required although marketing activities have in isolation a limited impact on take-up of interventions. In this simulation, the take-up does not alter the individual cost-effectiveness figures as the costs (excluding training) vary directly with the number of brief interventions undertaken. The direct costs of the intervention are low and therefore the results are highly sensitive to significant variations in assumptions. Indeed if health care cost savings arise from such interventions, as indicated in the Fleming et al study, there is potential for the NHS to save resources over time by implementing such interventions. However, there is no UK research on the size of such potential savings in a Scottish setting. Further research8.45 Brief interventions have been relatively well researched but evidence is required of their effectiveness when used routinely outwith a study setting. Specific interventions may be required for the successful implementation of a brief intervention programme and the costs and effectiveness of implementation strategies should be evaluated. Any further studies on brief interventions, per se, should focus on their longer-term effectiveness (most studies have 6-12 months follow up) and the added effectiveness when combined with medication. There is also potential to use monitoring information from pilot schemes to improve the potential economic simulations by substituting some actual costing data from these pilot schemes. The improved models could then be used to assess future schemes for their performance both in terms of costs and outcomes with reference to this research. Table 8.7 Summary of Brief Intervention Effectiveness Studies Reviewed
Table 8.5 Summary of Brief Intervention Cost-Effectiveness Studies Reviewed
< Previous | Contents | Next > | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Home | Topics | About | News | Publications | Consultations | Search | Links | Contacts | Help |
| Crown Copyright | Privacy policy | Content Disclaimer | General enquiries |